<DOC>
	<DOCNO>NCT01956188</DOCNO>
	<brief_summary>It demonstrate EPA DHA supplementation may anti-inflammatory property several chronic disease , namely , diabetes , obesity , rheumatoid arthritis , although controversy . Systemic lupus erythematosus autoimmune disease characterize chronic inflammatory state associate disease´s clinical symptom . Thus , hypothesize EPA DHA supplementation may beneficially affect inflammatory cytokine profile clinical feature LES patient .</brief_summary>
	<brief_title>Efficacy EPA DHA Supplementation Systemic Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Age 7 40 year SLEDAI ≤ 4 Cardiovascular dysfunction Rhythm conduction disorder Musculoskeletal disturbance Kidney pulmonary involvement Peripheral neuropathy Use tobacco Treatment lipidlowering hypoglycemic drug Fibromyalgia Use chronotropic antihypertensive drug Physically active subject</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>